Fundamental Analysis of POXEL SA(EPA:POXEL) stock

Fundamental Rating

Overall POXEL gets a fundamental rating of 1 out of 10. We evaluated POXEL against 76 industry peers in the Biotechnology industry. Both the profitability and financial health of POXEL have multiple concerns. POXEL is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year POXEL has reported negative net income.

In the past year POXEL has reported a negative cash flow from operations.

In the past 5 years POXEL reported 4 times negative net income.

In the past 5 years POXEL always reported negative operating cash flow.

1.2 Ratios

POXEL has a Return On Assets of -345.44%. This is amonst the worse of the industry: POXEL underperforms 95.77% of its industry peers.

		Industry Rank	Sector Rank
ROA	-345.44%
ROE	N/A
ROIC	N/A

ROA(3y)-60.88%

ROA(5y)-43.4%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 0.13%, POXEL perfoms like the industry average, outperforming 42.25% of the companies in the same industry.

The Profit Margin and Operating Margin are not available for POXEL so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	0.13%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

POXEL does not have a ROIC to compare to the WACC, probably because it is not profitable.

POXEL has more shares outstanding than it did 1 year ago.

The number of shares outstanding for POXEL has been increased compared to 5 years ago.

The debt/assets ratio for POXEL is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -13.52, we must say that POXEL is in the distress zone and has some risk of bankruptcy.

POXEL's Altman-Z score of -13.52 is on the low side compared to the rest of the industry. POXEL is outperformed by 87.32% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-13.52

ROIC/WACCN/A

WACC6.88%

2.3 Liquidity

A Current Ratio of 0.77 indicates that POXEL may have some problems paying its short term obligations.

The Current ratio of POXEL (0.77) is worse than 88.73% of its industry peers.

POXEL has a Quick Ratio of 0.77. This is a bad value and indicates that POXEL is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Quick ratio value of 0.77, POXEL is not doing good in the industry: 85.92% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	0.77
Quick Ratio	0.77

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for POXEL have decreased strongly by -42.62% in the last year.

POXEL shows a strong growth in Revenue. In the last year, the Revenue has grown by 650.49%.

POXEL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -33.77% yearly.

EPS 1Y (TTM)-42.62%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-78.52%

Revenue 1Y (TTM)650.49%

Revenue growth 3Y-70.61%

Revenue growth 5Y-33.77%

Sales Q2Q%509.64%

3.2 Future

The Earnings Per Share is expected to decrease by -8.92% on average over the next years.

POXEL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 86.16% yearly.

EPS Next Y39.72%

EPS Next 2Y2.27%

EPS Next 3Y-1.77%

EPS Next 5Y-8.92%

Revenue Next Year-49.6%

Revenue Next 2Y322.98%

Revenue Next 3Y54.02%

Revenue Next 5Y86.16%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

POXEL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year POXEL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y2.27%

EPS Next 3Y-1.77%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

POXEL does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

POXEL SA

EPA:POXEL (10/21/2024, 11:56:31 AM)

0.309

-0.01 (-2.98%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap16.48M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-345.44%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	0.13%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.12

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.77
Quick Ratio	0.77
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-42.62%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y39.72%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)650.49%

Revenue growth 3Y-70.61%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

POXEL SA (POXEL.PA)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens